Vaccination with p53-peptide?pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study
Inge Marie Svane(Copenhagen University Hospital), Mogens H. Claësson(University of Copenhagen), Kirsten Nikolajsen(Herlev Hospital), Anders Elm Pedersen(University of Copenhagen), Hans Erik Johnsen(Herlev Hospital), Claus Kamby(University of Copenhagen), Søren Buus(University of Copenhagen), Dorte Nielsen(Herlev Hospital), Eva Gaarsdal(Herlev Hospital)
Cited by 112
Related Papers
Effect of Obesity on Prognosis After Early-Stage Breast Cancer
|Journal of Clinical Oncology|2010|600
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
|The Lancet Oncology|2021|389
Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?
|Cancer Epidemiology Biomarkers & Prevention|2006|364